Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

CDSCO Panel Approves GSK's Proposal to Double Indian Patient Pool in Dostarlimab Trial

Parthika Patel15 July 2025 7:34 PM IST

New Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...

Girl With Fever Given Rabies Vaccine, Probe Ordered

SEC Flags Safety, Efficacy Gaps in Troikaa's Rapid IV Paracetamol Bolus Proposal, Seeks More Data

Parthika Patel12 July 2025 7:59 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined to approve Troikaa...

CDSCO Panel Recommends Phase IV Trial for Acne FDC Gel by Precise Biopharma

Parthika Patel9 July 2025 11:37 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...

CDSCO Panel Asks Dr Reddy's to Submit Indian Data for Triptorelin Pediatric Use

Parthika Patel8 July 2025 1:45 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Endocrinology and Metabolism division of the Central Drugs Standard Control Organisation...

Pfizer's Abrocitinib Phase III Data Accepted by CDSCO Expert Committee

Parthika Patel6 July 2025 10:00 AM IST

New Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...

Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis

Parthika Patel4 July 2025 3:00 PM IST

New Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...

Submit Full Adverse Event Data from Lenvatinib Phase IV Liver Cancer Trial: CDSCO Panel To Eisai Pharma

Parthika Patel4 July 2025 1:00 PM IST

New Delhi: In a recent regulatory review, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...

Sun Pharma Gets Relief As Delhi HC Bars Use of BERIVITAL, BEZOLIC, DOZE-30 For Trademark Infringement

Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate FDC

Parthika Patel2 July 2025 5:01 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organization (CDSCO) has...

CDSCO Clears Abbott's phase IV Trial Of Dydrogesterone MR Tablet

Parthika Patel30 Jun 2025 2:53 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organization (CDSCO) has approved...

Pfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine

Parthika Patel28 Jun 2025 7:23 PM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has granted Pfizer Limited...

CDSCO Asks Serum Institute to Revise Protocol for Trivalent Flu-COVID Vaccine Trial

Parthika Patel27 Jun 2025 10:53 PM IST

New Delhi: The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has reviewed a...

Medical Device Imports Still at 70%, India Spent Over USD 25 Billion in 5 Years: Parliament Informed

SEC Clears Hemopurifier Device for Cancer Study in Indian Patients

Parthika Patel26 Jun 2025 7:50 PM IST

New Delhi: In a step toward advancing medical device-based cancer care, the Subject Expert Committee (SEC) under the Oncology division of the Central...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok